A practical reference on PPARδ agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-02 and is reviewed periodically as new material appears.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
| Property | Value | Notes |
|---|---|---|
| IUPAC name | {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid | Systematic name for GW501516 |
| CAS Registry Number | 317318-70-0 | Unique identifier for the parent compound |
| Molecular formula | C21H18F3NO3S2 | Includes carbon, hydrogen, fluorine, nitrogen, oxygen, and sulfur |
| Molecular weight | 453.5 g/mol | Approximate value for the neutral form |
| Appearance | White to off-white powder | Typical description for purified laboratory material |
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Hezbollah's senior leadership faced the heaviest casualties in its entire history during the conflict. According to the IDF, 13 members of Hezbollah's senior command were killed. Its political council lost figures such as Secretary-General Hassan Nasrallah, who ruled the group for over three decades, and his deputy, Hashem Safieddine. Its armed wing lost key leaders such as Fuad Shukr, Hezbollah's military commander; Ibrahim Aqil, Shukr's deputy; and Ali Karaki, the commander of Hezbollah's Southern Front. Hezbollah also saw heavy damage inflicted upon its equipment, missile arsenal and infrastructure in southern Lebanon, weakening its operational capacity. Heavy damage was inflicted upon military infrastructure such as bases, tunnels, weapon depots, and fortifications, and its arms supply has been disrupted by Israeli strikes on Syrian border crossings. According to IDF, they confiscated over 155,000 weapons and pieces of military equipment belonging to Hezbollah, including around 12,000 explosive devices, drones, and other explosive weapons, more than 13,000 anti-tank missile launchers and rockets, and anti-aircraft missiles. In addition, over 121,000 communication devices, computers, electronic equipment and documents were also captured. In April 2025, in response to increasing calls for its disarmament, Hezbollah expressed willingness to engage in discussions about its weapons with Lebanese President Joseph Aoun. These discussions would be contingent upon Israel's withdrawal from five hilltop positions in southern Lebanon and the cessation of its military strikes.
H3O+(aq) + OH−(aq) ⇌ H2O(liq) + H2O(liq) Due to this equilibrium, any increase in the concentration of hydronium is accompanied by a decrease in the concentration of hydroxide. Thus, an Arrhenius acid could also be said to be one that decreases hydroxide concentration, while an Arrhenius base increases it. In an acidic solution, the concentration of hydronium ions is greater than 10−7 moles per liter. Since pH is defined as the negative logarithm of the concentration of hydronium ions, acidic solutions thus have a pH of less than 7.
NETA metabolizes into ethinylestradiol at a rate of 0.20 to 0.33% across a dose range of 10 to 40 mg. Peak levels of ethinylestradiol with a 10, 20, or 40 mg dose of NETA were 58, 178, and 231 pg/mL, respectively. For comparison, a 30 to 40 μg dose of oral ethinylestradiol typically results in a peak ethinylestradiol level of 100 to 135 pg/mL. As such, in terms of ethinylestradiol exposure, 10 to 20 mg NETA may be equivalent to 20 to 30 μg ethinylestradiol and 40 mg NETA may be similar to 50 μg ethinylestradiol. In another study however, 5 mg NETA produced an equivalent of 28 μg ethinylestradiol (0.7% conversion rate) and 10 mg NETA produced an equivalent of 62 μg ethinylestradiol (1.0% conversion rate). Due to its estrogenic activity via ethinylestradiol, high doses of NETA have been proposed for add-back in the treatment of endometriosis without estrogen supplementation. Generation of ethinylestradiol with high doses of NETA may increase the risk of venous thromboembolism but may also decrease menstrual bleeding relative to progestogen exposure alone.
In 1969, after completing her medical training, she became a lecturer at the Department of Bacteriology and Immunology in Glasgow's Western Infirmary teaching hospital. While working at the hospital she carried out research on the role of intra-epithelial lymphocytes in intestinal immunity, receiving her PhD in 1974. In 1975, she was appointed as a senior lecturer at the University of Edinburgh, also becoming a consultant at the Gastrointestinal Unit at the Western General Hospital in Edinburgh. In 1987 she was appointed to a personal professorship in gastroenterology. From 1991 to 1994 she was head of the Department of Medicine at the university. She published more than 250 papers in peer-reviewed academic journals, published three books and contributed chapters to many other books. Her research provided new insights into the mechanisms responsible for Crohn's and coeliac diseases which led to significant advances in the therapy of these conditions. She also carried out significant research on oral tolerance. She served on the Committee on Safety of Medicines, the Medical Research Council Gene Therapy Advisory Board, and the Spongiform Encephalopathy Advisory Committee. At the time of her death she was president of the Society for Mucosal Immunology. She was a consultant providing advice and training to the International Centre for Diarrhoeal Disease Research in Bangladesh.
=== Metabolism === Methocarbamol is the carbamate derivative of guaifenesin, but does not produce guaifenesin as a metabolite, because the carbamate bond is not hydrolyzed metabolically; its metabolism is by Phase I ring hydroxylation and O-demethylation, followed by Phase II conjugation. All the major metabolites are unhydrolyzed carbamates. Small amounts of unchanged methocarbamol are also excreted in the urine.
Sources: en.wikipedia.org
== Side effects and contraindications == The side effects encountered are anorexia, nausea, diarrhea, metallic taste, and weight loss. Its use is contraindicated in diabetic coma, ketoacidosis, severe infection, trauma, other conditions where buformin is unlikely to control the hyperglycemia, renal or hepatic impairment, heart failure, recent myocardial infarct, dehydration, alcoholism, and conditions likely to predispose to lactic acidosis.
In January 2021, the United States designated the Houthis a terrorist organization, creating fears of an aid shortage in Yemen, but this stance was reversed a month later after Joe Biden became president. On 17 January 2022, Houthi missile and drone attacks on UAE industrial targets set fuel trucks on fire and killed three foreign workers. This was the first specific attack to which the Houthi admitted, and the first to result in deaths. A response led by Saudi Arabia included a 21 January air strike on a detention centre in Yemen, resulting in at least 70 deaths. Following the outbreak of the Gaza war, the Houthis began to fire missiles at Israel and to attack ships off Yemen's coast in the Red Sea, which they say is in solidarity with the Palestinians and aiming to facilitate entry of humanitarian aid into the Gaza Strip. On 31 October Houthi forces launched ballistic missiles at Israel, which were shot down by Israel's Arrow missile defense system. Israeli officials claimed that this was the first ever combat to occur in space. In order to end the attacks in the Red Sea, the Houthis demanded a ceasefire in Gaza and an end to Israel's blockade of the Gaza Strip. In January 2024, the United States and the United Kingdom conducted airstrikes against multiple Houthi targets in Yemen, and the United States designated the Houthi as a Specially Designated Global Terrorist (SDGT). In February 2026, the Houthis announced that they had resumed attacks on ships in response to the recent US and Israeli airstrikes on Iran.
The white shark's genome has remained relatively stable in its evolution. As a species, it does not behave as a unified metapopulation at the global scale. Instead, populations within the major ocean basins show distinct genetic lineages that diverged from each other at least thousands of years ago. A 2020 mitochondrial DNA (mDNA) (mother-inherited) study concluded that Mediterranean sharks show closer affinity with Australia/New Zealand and Northeastern Pacific sharks than with sharks from South Africa and the Northwestern Atlantic. The researchers suggested that, over 3 mya, sharks from the former region swam to South Africa and north in response to Pleistocene climatic cycles and ended up in the Mediterranean. A 2024 study cautioned that mDNA is "informative about the species' deep history but are of very limited use for estimating recent connectivity". Using nuclear DNA (both mother- and father-inherited), the study concluded that white shark populations can be divided into three major branches or clades: North Atlantic (represented by the US East Coast and Mediterranean), Indo-Pacific (represented by Australia, New Zealand and South Africa), and North Pacific (represented by California, Baja California, and East Asia). These diverged relatively recently, around 100,000–200,000 years ago, in response to lowered sea levels. A 2025 study affirmed the existence of these three clades but found that they diverged around 7,000 years ago following a decline in the global white shark population, which started 800,000 years ago.
The set nature of species, and thus the absoluteness of creatures' places in the great chain, came into question during the 18th century. The dual nature of the chain, divided yet united, had always allowed for seeing creation as essentially one continuous whole, with the potential for overlap between the links. Radical thinkers like Jean-Baptiste Lamarck saw a progression of life forms from the simplest creatures striving towards complexity and perfection, a schema accepted by zoologists like Henri de Blainville. The very idea of an ordering of organisms, even if supposedly fixed, laid the basis for the idea of transmutation of species, whether progressive goal-directed orthogenesis or Charles Darwin's undirected theory of evolution. The chain of being continued to be part of metaphysics in 19th-century education, and the concept was well known. The geologist Charles Lyell used it as a metaphor in his 1851 Elements of Geology description of the geological column, where he used the term "missing links" about missing parts of the continuum. The term "missing link" later came to signify transitional fossils, particularly those bridging the gulf between man and beasts.
Sources: en.wikipedia.org
== Summary table for each class of nuclides == This is a summary table for the 987 nuclides with half-lives longer than one hour, given in List of nuclides. Note that that number, while exact to present knowledge, will likely change slightly in the future, as some "stable" nuclides are observed to be radioactive with very long half-lives, and some half-lives or known radioactive ones are revised.
=== As an invasive species === Although listed as an invasive species in several countries, one source reports that M. oleifera has "not been observed invading intact habitats or displacing native flora", so "should be regarded at present as a widely cultivated species with low invasive potential."
An adult penis with an erect length of 2.5 standard deviations (SD) below the average but otherwise formed normally is referred to in a medical context as having the micropenis condition. The condition affects 0.6% of men. Some of the identifiable causes are deficiency of pituitary growth hormone or gonadotropins, mild degrees of androgen insensitivity, a variety of genetic syndromes and variations in certain homeobox genes. Some types of micropenis can be addressed with growth hormone or testosterone treatment in early childhood. Operations are also available to increase penis size in cases of micropenis in adults.
Steven Ruggles (born May 8, 1955) is Regents Professor of History and Population Studies at the University of Minnesota, and the director of the IPUMS Center for Data Integration. He received a 2022 MacArthur "Genius" award. Ruggles is best known as the creator of IPUMS, the world's largest population database. IPUMS provides information about two billion people residing in 159 countries between 1703 and the present, including every respondent to the surviving U.S. censuses of 1790 to 1950. He served as founding director of the Minnesota Population Center from 2000 to 2016 and the Institute for Social Research and Data Innovation from 2016 to 2023. He served as the 2015 President of the Population Association of America, the first historian to hold the position. He also served as President of the Association of Population Centers (2017–2018) and President of the Social Science History Association (2018–2019). He has been active on many national advisory and study committees, including the Census Bureau Scientific Advisory Committee; the National Science Foundation Social, Behavioral, and Economic Sciences Advisory Committee; the National Science Foundation Advisory Committee for CyberInfrastructure; and the National Academy of Sciences Board on Research Data and Information. Ruggles completed a BA at the University of Wisconsin–Madison (1978), followed by at the University of Pennsylvania an MA (1982) and PhD (historical demography, 1984).
The batch-to-batch variations arising from the needs during the mentioned methodology can be overcome by utilizing technical components for mixing and growth as well as transport and temperature adjustments. For the production of CdSe based semiconductor nanoparticles this method has been investigated and tuned to production amounts of kilograms per month. Since the use of technical components allows for easy interchange in regards of maximum throughput and size, it can be further enhanced to tens or even hundreds of kilograms. In 2011 a consortium of U.S. and Dutch companies reported a milestone in high-volume quantum dot manufacturing by applying the traditional high temperature dual injection method to a flow system. On 23 January 2013 Dow entered into an exclusive licensing agreement with UK-based Nanoco for the use of their low-temperature molecular seeding method for bulk manufacture of cadmium-free quantum dots for electronic displays, and on 24 September 2014 Dow commenced work on the production facility in South Korea capable of producing sufficient quantum dots for "millions of cadmium-free televisions and other devices, such as tablets". Mass production was due to commence in mid-2015. On 24 March 2015, Dow announced a partnership deal with LG Electronics to develop the use of cadmium free quantum dots in displays.
Sources: en.wikipedia.org
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.
It is prohibited by the World Anti-Doping Agency as a hormone and metabolic modulator. Athletes who test positive for GW501516 can face sanctions, including suspensions and loss of results.
Cardarine is a common or trade-style name, while GW501516 is the research code for the same chemical entity. Some sources also use Endurobol or GSK-516. The names refer to the same compound, not distinct drugs.
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.